rdf:type |
|
lifeskim:mentions |
umls-concept:C0002453,
umls-concept:C0008976,
umls-concept:C0034380,
umls-concept:C0085533,
umls-concept:C0120107,
umls-concept:C0279752,
umls-concept:C0332283,
umls-concept:C0600142,
umls-concept:C0695347,
umls-concept:C1512890,
umls-concept:C1707455
|
pubmed:issue |
3
|
pubmed:dateCreated |
2007-1-19
|
pubmed:abstractText |
The purpose of this article is to compare quality of life (QOL) and menopausal symptoms among premenopausal patients with lymph node-negative breast cancer receiving chemotherapy, goserelin, or their sequential combination, and to investigate differential effects by age.
|
pubmed:grant |
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1527-7755
|
pubmed:author |
pubmed-author:AebiStefanS,
pubmed-author:BernhardJürgJ,
pubmed-author:Castiglione-GertschMonicaM,
pubmed-author:CoatesAlan SAS,
pubmed-author:CollinsJohnJ,
pubmed-author:ForbesJohn FJF,
pubmed-author:GelberRichard DRD,
pubmed-author:GoldhirschAronA,
pubmed-author:HürnyChristophC,
pubmed-author:International Breast Cancer Study Group Trial VIII,
pubmed-author:MurrayElizabethE,
pubmed-author:PriceKaren NKN,
pubmed-author:ThürlimannBeatB,
pubmed-author:ZahriehDavidD
|
pubmed:issnType |
Electronic
|
pubmed:day |
20
|
pubmed:volume |
25
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
263-70
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:17159194-Adult,
pubmed-meshheading:17159194-Age Factors,
pubmed-meshheading:17159194-Amenorrhea,
pubmed-meshheading:17159194-Antineoplastic Agents, Hormonal,
pubmed-meshheading:17159194-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:17159194-Breast Neoplasms,
pubmed-meshheading:17159194-Chemotherapy, Adjuvant,
pubmed-meshheading:17159194-Cyclophosphamide,
pubmed-meshheading:17159194-Female,
pubmed-meshheading:17159194-Fluorouracil,
pubmed-meshheading:17159194-Goserelin,
pubmed-meshheading:17159194-Hot Flashes,
pubmed-meshheading:17159194-Humans,
pubmed-meshheading:17159194-Methotrexate,
pubmed-meshheading:17159194-Middle Aged,
pubmed-meshheading:17159194-Premenopause,
pubmed-meshheading:17159194-Quality of Life,
pubmed-meshheading:17159194-Treatment Outcome
|
pubmed:year |
2007
|
pubmed:articleTitle |
Adjuvant chemotherapy followed by goserelin compared with either modality alone: the impact on amenorrhea, hot flashes, and quality of life in premenopausal patients--the International Breast Cancer Study Group Trial VIII.
|
pubmed:affiliation |
International Breast Cancer Study Group (IBCSG), Bern, Switzerland. juerg.bernhard@ibcsg.org
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Research Support, N.I.H., Extramural
|